Literature DB >> 710825

A case of Menetrier's disease associated with protein-losing gastropathy and abnormal serum complement profile.

M Kondo, H Nishibori, M Ikezaki, S Takemura, M Masuda.   

Abstract

A 44-year-old man with Menetrier's disease associated with protein-losing gastropathy and with abnormal serum complement profile is reported. He was treated by an antifibrinolytic compound tranexamic acid (trans-AMCHA) since he was found to have elevated fibrinolytic activity in the biopsied gastric mucosa. The therapy brought his serum protein from 3.8 g/dl to 5.6g/dl, however could not reduce his mucosal disorder. Substitution of a placebo for trans-AMCHA resulted in marked depression of his serum protein to 3.7 g/dl. It was concluded that trans-AMCHA was effective in raising his serum protein to a certain extent but failed to block the vicious circle of "mucosal disorder", "increased tissue fibrinolysis" and "hypoproteinemia" (Kondo, M. et al. Gastroenterology 70, 1045, 1976). Abnormal serum complement profile seen in this patient was found to be due to cold activation of the classical complement pathway (Kondo, M. et al. J. Immunol. 117, 486, 1976). Although no correlation between the phenomenon and Menetrier's disease has been clarified yet, the appearance of wheezing as in asthma when exposed to cold suggested that cold activation of complement occurred in vivo and resulted in increasing of the vascular permeability in the lungs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 710825     DOI: 10.1007/bf02774053

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  15 in total

1.  The role of the gastrointestinal system in "idiopathic hypoproteinemia".

Authors:  T A WALDMANN; J L STEINFELD; T F DUTCHER; J D DAVIDSON; R S GORDON
Journal:  Gastroenterology       Date:  1961-09       Impact factor: 22.682

2.  The mechanism of hypoproteinemia in patients with regional enteritis and ulcerative colitis.

Authors:  J L STEINFELD; J D DAVIDSON; R S GORDON; F E GREENE
Journal:  Am J Med       Date:  1960-09       Impact factor: 4.965

3.  Hypoproteinemia antedating intestinal lesions, and possibly due to excessive serum protein loss into the intestine.

Authors:  H HOLMAN; W F NICKEL; M H SLEISENGER
Journal:  Am J Med       Date:  1959-12       Impact factor: 4.965

4.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

5.  Differences between plasma and serum complement in patients with chronic liver disease.

Authors:  S Inai; H Kitamura; T Fujita; J Kojima; K Nagaki
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

6.  Titration of the first component of complement on a molecular basis: suitability of IgM and unsuitability of IgG hemolysins as sensitizer.

Authors:  H R Colten; T Borsos; H J Rapp
Journal:  Immunochemistry       Date:  1969-05

7.  Cold activation of complement i. presence of coagulation-related activator.

Authors:  M Kondo; K Hosokawa; M Masuda
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

8.  Tissue plasminogen activator in the pathogenesis of protein-losing gastroenteropathy.

Authors:  M Kondo; T Bamba; K Hosokawa; S Hosoda; K Kawai; M Masuda
Journal:  Gastroenterology       Date:  1976-06       Impact factor: 22.682

9.  Treatment of protein-losing gastropathy with atropine.

Authors:  M N Gordon; E J Schaefer; M Finkel
Journal:  Am J Gastroenterol       Date:  1976-12       Impact factor: 10.864

10.  Experimental protein-losing gastroenteropathy: role of tissue plasminogen activator.

Authors:  M Kondo; K Nakanishi; T Bamba; K Hosokawa; M Masuda
Journal:  Gastroenterology       Date:  1976-10       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.